Back

A prospective pilot study to identify a myocarditis cohort who may safely resume sports activities 3 months after diagnosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Cardiovascular magnetic resonance in myocarditis/HCM Myocardial Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Dimitri Patriki

University Hospital Zurich, Zurich (Switzerland)

10 More presentations in this session

Presentation thumbnail
The impact of sarcomeric mutations on myocardial fibrosis and ventricular diastolic function in hypertrophic cardiomyopathy (SADS-TW HCM registry study)
Professor J. Juang (Taipei, TW)
Abstract
Presentation thumbnail
Impaired myocardial deformation assessed by cardiac magnetic resonance is associated with increased arrhythmic risk in hypertrophic cardiomyopathy
Doctor A. Barbosa (Santa Maria da Feira, PT)
Abstract
Presentation thumbnail
4D-flow cardiac magnetic resonance analysis of left ventricular blood flow dynamics in mid-ventricular obstructive hypertrophic cardiomyopathy
Doctor K. Miyajima (Hamamatsu, JP)
Abstract Slides
Presentation thumbnail
Right versus Left Ventricular Remodelling after Surgical myectomy for HOCM
Mr M. Abdelkhalek (Aswan, EG)
Abstract Slides
Presentation thumbnail
Trabecular complexity as a subclinical structural alteration in fabry cardiomyopathy: a cardiac magnetic resonance study
Doctor D. Lazzeroni (Parma, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Cardiovascular magnetic resonance in myocarditis/HCM

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis
thumbnail
Congress Presentation
CMR for inflammation, oedema, and the pericardium

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources